Condition 1: congenital heart diseases. Condition 2: malnutrition. Congenital malformation of heart, unspecified Sequelae of malnutrition and other nutritional deficiencies
Conditions
Interventions
Intervention group: In this study, infants on regular infant formula will be switched completely to energy- and nutrient-dense formula (100 kcal and 2.6 g protein per 100 ml
Infatrini®, Nutricia, Zoetermeer, the Netherlands). Infants who receive a combination of breast milk and regular infant formula will continue breast milk in addition to energy- and nutrient-dense form
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
No minimum to 9 Months
Inclusion criteria
Inclusion criteria: children with moderate/high risk cardiac defects who are candidates for surgical repair being undernourished (Weight For Age z-score = - 2)
Exclusion criteria
Exclusion criteria: Infants known to have non-cardiac medical problems that could independently affect nutrient intake, such as gastrointestinal malformations, renal failure, liver disease, neurological sequelae genetic conditions associated with growth failure Infants with low risk cardiac defects presence of cow’s milk allergy and galactosaemia history of operation within 4 weeks from the time of screening receiving parenteral nutrition
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Weight for age Z score. Timepoint: 3,6,9,12 weeks after the administration of the high-energy- high protein formula. Method of measurement: scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Weight for length Z score. Timepoint: 3,6,9,12 weeks after the administration of the high energy-high protein formula. Method of measurement: scale and meter.;Length for age Z score. Timepoint: 3,6,9,12 weeks after the administration of the high energy-high protein formula. Method of measurement: meter.;Head circumference. Timepoint: 3,12 weeks after the administration of the high energy-high protein formula. Method of measurement: meter.;Mid-upper arm circumference. Timepoint: 3,12 weeks after the administration of the high energy-high protein formula. Method of measurement: meter. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactEhsan Aghaei Moghadam
Tehran University of Medical Sciences
Outcome results
None listed